Seeing Is Believing

Currently out of the existing stock ratings of Bruce Nudell, 38 are a BUY (90.48%), 4 are a HOLD (9.52%).
Analyst Bruce Nudell, carries an average stock price target met ratio of 75% that have a potential upside of 20.1% achieved within 373 days. Previously, Bruce Nudell worked at TRUIST, CREDIT SUISSE.
Bruce Nudell’s has documented 88 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ABMD, ABIOMED at 14-May-2019.
Analyst best performing recommendations are on AXNX (AXONICS MODULATION TECHNOLOGIES).
The best stock recommendation documented was for AXNX (AXONICS MODULATION TECHNOLOGIES) at 5/10/2019. The price target of $33 was fulfilled within 18 days with a profit of $3.05 (10.18%) receiving and performance score of 5.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 07-Oct-2026
$20
$-4.35 (-17.86%)
$27
Hold Since 05-Oct-2026
$27
$2.65 (10.88%)
$28
Hold Since 28-Oct-2022
$23
$-1.35 (-5.54%)
$19
2 months 9 days ago
(31-Jul-2026)
7/22 (31.82%)
$-3.15 (-12.05%)
99
Hold Since 08-Oct-2024
$29
$4.65 (19.10%)
$24
2 months 9 days ago
(31-Jul-2026)
12/22 (54.55%)
$2.85 (10.90%)
242
Hold Since 30-Oct-2025
$28
$3.65 (14.99%)
$24
2 months 9 days ago
(31-Jul-2026)
6/19 (31.58%)
$1.85 (7.07%)
195